A double-blind, randomized, multicentric, placebo-controlled clinical trial of antarth, a phytomedicine, in the treatment of osteoarthritis

Indian Journal of Pharmacology

Volumn 43, Issue 1, 2011, Pages 69-72

  Gupta, Anil K ^a   Acharya, Kirankumar ^b   Sancheti, Parag S ^c   Joshi, Ramchandra S ^d  

^a GSVM MEDICAL COLLEGE   (India)

^b Department of Orthopaedics   (India)

^c Sancheti Institute for Orthopaedics and Rehabilitation   (India)

^d 14 Shiv Shanti Juhu Versova Link Road ^*  (India)

Author keywords

Functional disability; global assessment; rescue medication; Visual Analog Scale

Indexed keywords

ANTARTH; AYURVEDIC DRUG; DICLOFENAC; HERBACEOUS AGENT; PLACEBO; RANITIDINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AYURVEDA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OSTEOARTHRITIS; PAIN ASSESSMENT; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

EID: 78951479243     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.75674     Document Type: Article

References (13)

1. Brooks PM, March LM. New insights into osteoarthritis. Med J Aust 1995;163:367-9.
2. Tramer MR, Moore RA, Raynold DJ, McQuay HJ. Quatitative estimation of rare adverse events which follow a biological progression: A new model applied to chronic NSAIDs use. Pain 2000;85:169-82.
3. Bachanan W. Implications of NSAID therapy in elderly patients. J Rheumatol 1990;4:29-32.
4. Caradoc-Davies TH. Non-steroidal anti-inflammatory drugs, arthritis and gastrointestinal bleeding in elderly in-patients. Age Ageing 1984;13:295-8.
5. Turek SL. Orthopaedics: Principles and their application. Degenerative joint diseases. 4 th ed. Philadelphia: J.B. Lippincott Company; 1984. p. 384-416.
6. Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of paracetamol, aspirin, and nonsteroidal anti-inflammatory drugs. N Engl J Med 1994;331:1675-9.
7. Schiodt FV, Rochling FA, Casey DL, Lee WM. Paracetamol toxicity in an urban county hospital. N Engl J Med 1997;337:1112-7.
8. Whitcomb DC, Block GD. Association of paracetamol hepatotoxicity with fasting and ethanol use. JAMA 1994;273:1845-50.
9. Seifert CF, Lucas DS, Vondracek TG, Kastens DJ, McCarty DL, Bui B. Patterns of paracetamol use in alcoholic patients. Pharmacotherapy 1993;13:391-5.
10. Griffin MR, Ray WA, Schaffner W. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med 1988;109:359-63.
11. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991;114:63. 257-63.
12. Smalley WE, Griffin MR. The risks and costs of upper gastrointestinal disease attributable to NSAIDs. Gastroenterol Clin North Am 1996;25:373-96.
13. Crofford LJ, Lipsky PE, Brooks P, Abramson SB, Simon LS, van de Putte LB. Basic biology and clinical application of specific cyclooxygenase-2 inhibitors. Arthritis Rheum 2000;43:4-13.